We are live on ! Find out more
SAM

Silverback Asset Management Portfolio holdings

AUM $699M
1-Year Est. Return 72.42%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+72.42%
3 Year Est. Return
+92.45%
5 Year Est. Return
+84.79%
10 Year Est. Return
+101.08%
AUM
$718M
AUM Growth
-$11.2M
Cap. Flow
-$602M
Cap. Flow %
-83.86%
Top 10 Hldgs %
31.76%
Holding
94
New
6
Increased
3
Reduced
3
Closed
8

Top Buys

Rank Stock Value
1
RDNW
RideNow Group
RDNW
+$2.45M
2
VERI icon
Veritone
VERI
+$724K
3
VAL icon
Valaris
VAL
+$171K
4
NE icon
Noble Corp
NE
+$58.4K

Sector Composition

Rank Sector Weight
1 Energy 1.26%
2 Consumer Discretionary 1.05%
3 Technology 0.64%
4 Healthcare 0.12%
5 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$23.8M 3.31%
+50,000
New +$22.3M
INFN
2
PUT
DELISTED
Infinera Corporation Common Stock
INFN
$19.3M 2.69%
+250,000
New +$983K
RDNW
3
RideNow Group
RDNW
$256M
$7.56M 1.05%
928,777
+381,777
+70% +$2.45M
NE icon
4
Noble Corp
NE
$6.54B
$3.47M 0.48%
90,256
+1,250
+1% +$58.4K
AKTS
5
DELISTED
Akoustis Technologies Inc
AKTS
$2.8M 0.39%
3,353,351
-103,663
-3% -$69.7K
VAL icon
6
Valaris
VAL
$5.14B
$2.74M 0.38%
40,000
+2,500
+7% +$171K
STNG icon
7
Scorpio Tankers
STNG
$3.91B
$2.74M 0.38%
45,000
-5,000
-10% -$282K
MX icon
8
Magnachip Semiconductor
MX
$110M
$1.65M 0.23%
220,000
AVDL
9
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$1.41M 0.2%
+100,000
New +$1.17M
ESPR
10
DELISTED
Esperion Therapeutics
ESPR
$603K 0.08%
100,000
LAB icon
11
Standard BioTools
LAB
$342M
$276K 0.04%
125,000
-175,000
-58% -$374K
VERI icon
12
Veritone
VERI
$92.9M
$163K 0.02%
+324,922
New +$724K
VRM icon
13
Vroom Inc
VRM
$36.4M
$151K 0.02%
3,125
TELL
14
DELISTED
Tellurian Inc.
TELL
$121K 0.02%
160,200
DNMR
15
PUT
DELISTED
Danimer Scientific, Inc.
DNMR
$58.1K 0.01%
+1,425
New +$77.5K
AKTS
16
CALL
DELISTED
Akoustis Technologies Inc
AKTS
$56K 0.01%
+67,100
New +$45.1K
ADTH
17
DELISTED
AdTheorent Holding Co
ADTH
$1.09K ﹤0.01%
27,191
AISP
18
Airship AI Holdings
AISP
$58.9M
$725 ﹤0.01%
12,500
SHAP
19
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
$375 ﹤0.01%
12,500
ZAPP
20
DELISTED
Zapp Electric Vehicles
ZAPP
$65 ﹤0.01%
398
QDRO
21
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$7 ﹤0.01%
366
AVDL
22
DELISTED
Avadel Pharmaceuticals
AVDL
-100,000
Closed -$1.17M
PRCH icon
23
Porch Group
PRCH
$1.35B
-225,000
Closed -$181K
SPY icon
24
State Street SPDR S&P 500 ETF Trust
SPY
$771B
-100,000
Closed -$44.5M
TVTX icon
25
Travere Therapeutics
TVTX
$5.17B
-40,000
Closed -$358K

Similar funds

Silverback Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Silverback Asset Management held 94 positions worth $718M, down 1.5% from $730M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Silverback Asset Management withdrew a net $602M in Q4 2023, closing 8 positions and reducing 3 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $44.5M position sold in full.

By sector, the portfolio is most concentrated in Energy at 1.3% of assets, down from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Silverback Asset Management opened a new position in Veritone worth $163K.

  • Silverback Asset Management's largest Q4 2023 buy was Veritone: 324,922 shares worth $163K.
  • Silverback Asset Management added most to RideNow Group in Q4 2023, an estimated $2.45M increase.
  • Silverback Asset Management's biggest Q4 2023 reduction was Standard BioTools, cutting an estimated $374K.
  • Silverback Asset Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $44.5M.
  • Silverback Asset Management's ten largest holdings make up 32% of its $718M portfolio in Q4 2023.
  • Silverback Asset Management opened 6 new positions and closed 8 in Q4 2023.
  • Silverback Asset Management's portfolio value fell 1.5% quarter-over-quarter to $718M.

Based on Silverback Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.